EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS

EFFICACY AND SAFETY OF ORIGINAL DRUG BASED ON HEXAPEPTIDE SUCCINATE IN COMPLEX COVID-19 THERAPY IN ADULTS HOSPITALIZED PATIENTS

Currently, there are data that that make it possible to speak about a high clinical efficacy of the use of succinic salt of tyrosyl-D-alanyl-glycyl-phenylalanyl-leucyl-arginine (hexapeptide succinate) for the COVID-19 treatment. This article is devoted to the results of clinical trials of the origin...

Full description

Bibliographic Details
Main Authors: L. A. Balykova, O. A. Radaeva, K. Ya. Zaslavskaya, P. A. Bely, V. F. Pavelkina, N. A. Pyataev, A. Yu. Ivanova, G. V. Rodoman, N. E. Kostina, V. B. Filimonov, E. N. Simakina, D. A. Bystritsky, A. S. Agafyina, K. N. Koryanova, D. Yu. Pushkar
Format: Article
Language:Russian
Published: Volgograd State Medical University, Pyatigorsk Medical and Pharmaceutical Institute 2023-02-01
Series:Фармация и фармакология (Пятигорск)
Subjects:
амбервин
гексапептида сукцинат
острый респираторный дистресс-синдром
«цитокиновый шторм»
covid-19
тирозил-d-аланил-глицил-фенилаланил-лейцил-аргинина сукцинат
Online Access:https://www.pharmpharm.ru/jour/article/view/1222

Internet

https://www.pharmpharm.ru/jour/article/view/1222

Similar Items